Related Experiment Video
Updated: May 29, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Unrepairable DNA double-strand breaks initiate cytotoxicity with HSV-TK/ganciclovir
B Ladd1, J J O'Konek, L J Ostruszka
1Department of Pharmacology, University of Michigan Medical Center, Ann Arbor, MI 48109-5633, USA.
Abstract:
The herpes simplex virus thymidine kinase (HSV-TK) is the most widely used suicide gene in cancer gene therapy due to its superior anticancer activity with ganciclovir (GCV) compared with other HSV-TK substrates, such as 1-β-D-arabinofuranosyl thymine (araT). We have evaluated the role of DNA damage as a mechanism for the superiority of GCV. Using γ-H2AX foci as an indicator of DNA damage, GCV induced ≥ sevenfold more foci than araT at similar cytotoxic concentrations. The number of foci decreased after removal of either drug, followed by an increase in Rad51 foci indicating that homologous recombination repair (HRR) was used to repair this damage. Notably, only GCV produced a late and persistent increase in γ-H2AX foci demonstrating the induction of unrepairable DNA damage. Both drugs induced the ATR damage response pathway, as evidenced by Chk1 activation. However, GCV resulted in greater activation of ATM, which coincided with the late induction of γ-H2AX foci, demonstrating the presence of DNA double-strand breaks (DSBs). The increase in DSBs after Rad51 induction suggested that they occurred as a result of a failed attempt at HRR. These data demonstrate that the late and unrepairable DSBs observed uniquely with GCV account for its superior cytotoxicity and further suggest that inhibition of HRR will enhance cytotoxicity with HSV-TK/GCV.
Insights
Ganciclovir (GCV) shows superior cancer gene therapy efficacy over araT by causing more DNA damage. This unrepairable DNA damage, particularly double-strand breaks, explains GCV's enhanced cell-killing ability.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The herpes simplex virus thymidine kinase (HSV-TK) suicide gene system is crucial in cancer gene therapy.
- Ganciclovir (GCV) demonstrates superior anticancer activity compared to other substrates like araT.
Purpose of the Study:
- To investigate the role of DNA damage in explaining GCV's enhanced efficacy.
- To compare the DNA damage profiles induced by GCV and araT in HSV-TK cancer gene therapy.
Main Methods:
- Quantification of DNA damage using γ-H2AX foci as a biomarker.
- Assessment of DNA repair mechanisms, including homologous recombination repair (HRR) via Rad51 foci.
- Analysis of DNA damage response pathways (ATR and ATM) and Chk1/ATM activation.
Main Results:
- GCV induced significantly more γ-H2AX foci (indicating DNA damage) than araT at comparable cytotoxic doses.
- Both drugs triggered DNA repair pathways, with GCV uniquely causing late, persistent γ-H2AX foci and greater ATM activation, suggesting unrepairable DNA double-strand breaks (DSBs).
- DSBs appeared to result from failed HRR, particularly after GCV treatment.
Conclusions:
- The superior cytotoxicity of GCV in HSV-TK cancer gene therapy is attributed to its induction of late, unrepairable DNA DSBs.
- Targeting HRR in combination with HSV-TK/GCV therapy may further enhance its effectiveness.
More Related Videos
Related Concept Videos
Antiviral Nucleoside Inhibitors
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Fixing Double-strand Breaks
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Homologous Recombination

